Skip to main content
. 2021 Jun 9;2:100041. doi: 10.1016/j.crphar.2021.100041

Fig. 1.

Fig. 1

Diagrammatic representation of the two models of drug repositioning: conventional and extended profiling. The extended profiling model provides better outcomes with low failure rates and high efficacy along with time savings during the entire drug-development cycle.